Genomic Vision Logo

Genomic Vision

Provides DNA analysis and quality control for bioproduction and gene therapy.

GV | PA

Overview

Corporate Details

ISIN(s):
FR0011799907
LEI:
969500UXJNBY1C8Y8471
Country:
France
Address:
80 RUE DES MEUNIERS, 92220 BAGNEUX

Description

Genomic Vision is a biotechnology company specializing in the direct visualization and analysis of single DNA molecules through its proprietary Molecular Combing technology. This platform provides highly accurate characterization of large-scale genomic modifications, offering critical insights into genetic integrity and stability. The company's primary focus is on providing quality control (QC) solutions for the bioproduction and cell and gene therapy markets, ensuring the safety and efficacy of advanced therapeutic products. In drug discovery, its Replication Combing Assay (RCA) is used to assess the effects of compounds on DNA replication. Genomic Vision's tools and services support the entire lifecycle of biopharmaceutical development, from research to production.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-10-12 07:00
Inside Information / Other news releases
English 167.5 KB
2023-09-29 18:00
Inside Information / News release on accounts, results
English 180.6 KB
2023-09-29 18:00
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier …
French 2.6 MB
2023-09-29 18:00
Informations privilégiées / Communiqué sur comptes, résultats
French 211.7 KB
2023-09-18 18:30
Inside Information / Other news releases
English 179.4 KB
2023-09-18 18:30
Informations privilégiées / Autres communiqués
French 175.0 KB
2023-07-18 07:00
Informations privilégiées / Autres communiqués
French 164.7 KB
2023-07-18 07:00
Inside Information / Other news releases
English 165.6 KB
2023-07-07 18:00
Informations privilégiées / Autres communiqués
French 318.0 KB
2023-06-29 18:02
Informations privilégiées / Autres communiqués
French 118.3 KB
2023-06-28 18:00
Informations privilégiées / Autres communiqués
French 90.4 KB
2023-06-27 17:08
Franchissement de seuils
French 278.6 KB
2023-06-26 18:00
Total du nombre de droits de vote et du capital / Information relative au nombr…
French 103.5 KB
2023-06-23 18:00
Inside Information / Other news releases
English 168.4 KB
2023-06-23 18:00
Informations privilégiées / Autres communiqués
French 107.8 KB

Automate Your Workflow. Get a real-time feed of all Genomic Vision filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genomic Vision

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genomic Vision via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.